Porth Ymchwil

All Wales Medicines Strategy Group Final Appraisal Report - Alemtuzumab (MabCampath) for the treatment of patients with B-cell chronic lymphocytic leukaemia for whom fludarabine combination chemotherapy is not appropriate.

Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

  • D. Hughes
  • D.A. Hughes
  • [No Value] All Wales Strategy Group.
Iaith wreiddiolSaesneg
CyhoeddwrUnknown
Corff comisiynuNHS Wales
Argraffiad2008
StatwsCyhoeddwyd - 1 Ion 2008
Gweld graff cysylltiadau